Back to VA VANGUARD CAPITAL MANAGEMENT LLC
KROS2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in KEROS THERAPEUTICS INC
Yes. Vanguard Capital Management holds 833,596 shares of KROS (Keros Therapeutics), worth $8.9M, as of its Q2 2026 13F filing. It increased the position by 2,175 shares (+0.3%) from Q1 2026. Vanguard Capital Management has held KROS in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$8.9M
Current Shares
833,596
Total Value Change
-$259,411
Total Shares Change
+2,175
Quarter-by-Quarter History
Other major holders of KROS: FMR LLC